About AIC

Arthritis Innovation Corporation (AIC) is a clinical-stage pharmaceutical company addressing unmet needs in Orthopedic Surgery and Arthritis management. A private company founded in 2013, AIC leverages a world-class product development team in Toronto, Canada and Denver, Colorado, with a proprietary polymer drug delivery system (BEPO™). 

The Company's first drug in Phase 2 clinical testing uses sustained local delivery of an NSAID after total knee replacement (TKR) to manage pain and inflammation as an alternative to oral NSAIDs or narcotics.                                                                                                                                                                                                                  Clinicaltrials.gov Identifier: NCT03541655.   For more information, click HERE.